Rajiv Shah, MD
Interventional Pain Medicine · Cottonwood Heights, UTNPI 1285664185
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 263 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for interventional pain medicine clinicians in UT, where the typical reported total is $7,299.
Across 263 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$797
- Nevro Corp.$464
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$403
- Abbott$340
- Boston Scientific$330
- AbbVie$318
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,510100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 71 | $797 |
| Nevro Corp. | 14 | $464 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $403 |
| Abbott | 5 | $340 |
| Boston Scientific | 20 | $330 |
| AbbVie(2 entities) | 16 | $318 |
| Pfizer | 26 | $252 |
| Biodelivery Sciences International, Inc. | 13 | $225 |
| Spinefrontier, Inc. | 1 | $184 |
| Globus Medical | 6 | $156 |
| Idorsia Pharmaceuticals US Inc | 6 | $110 |
| Amgen | 6 | $99 |
| Teva Pharmaceuticals USA, Inc. | 5 | $83 |
| Daiichi Sankyo Inc. | 5 | $79 |
| Almatica Pharma LLC | 4 | $72 |
| Medtronic(2 entities) | 4 | $70 |
| Zyla Life Sciences, Inc. | 5 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $43 |
| Stratus Medical, LLC | 3 | $42 |
| Biohaven Pharmaceuticals, Inc. | 3 | $42 |
| Nalu Medical, Inc. | 2 | $42 |
| Shionogi Inc | 2 | $37 |
| AstraZeneca | 3 | $35 |
| Vertex | 2 | $31 |
| Scilex Pharmaceuticals Inc. | 2 | $24 |
| Relievant Medsystems, Inc. | 1 | $20 |
| Si-bone, Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| GRT US Holding, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
| Assertio Therapeutics, Inc. | 1 | $14 |
| Virtus Pharmaceuticals LLC | 1 | $13 |
| Merck | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Kaleo, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lamitrode SCS Leads$214
- InSpan$184
- SIJFuse$184
- FacetFuse$184
- NanoFuse$184
How this compares
$4,510 in reported general payments places this provider in the 30th percentile of 26 interventional pain medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 252 | $8,914 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 252 | $7,651 |
| Oxycodone Hcl | 155 | $3,008 |
| Lubiprostone | 25 | $2,376 |
| Fentanyl | 20 | $2,113 |
| Morphine Sulfate ErMorphine Sulfate | 41 | $1,148 |
| Tramadol Hcl | 116 | $1,096 |
| Hydromorphone Hcl | 58 | $837 |
| Gabapentin | 64 | $679 |
| Morphine Sulfate | 16 | $625 |
| Pregabalin | 37 | $550 |
| Celecoxib | 28 | $497 |
| Tizanidine Hcl | 24 | $450 |
| Carisoprodol | 26 | $409 |
| Ropinirole Hcl | 32 | $309 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Cottonwood Heights
- Kyle MatsumuraCottonwood Heights$2K
- Arun RajagopalCottonwood Heights$1K
- Bryan HoelzerVineyard$718K
- Nathan ClementsSaint George$29K
- Rick ObraySt George$23K
- Brian RichardsonLogan$19K
- Alex NelsonMurray$17K
- Steven LarsenSaint George$14K
- J Riley StringhamProvo$13K
- Craig DavisWest Jordan$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.